# AML Treatment in Untreated Adult Patients

> **NCT00449319** · NA · UNKNOWN · sponsor: **Gruppo Italiano Malattie EMatologiche dell'Adulto**

## Conditions studied

- Leukemia, Myelocytic, Acute

## Interventions

- **PROCEDURE:** Identification of appropriate therapies according to risks factors
- **DRUG:** Daunorubicine
- **PROCEDURE:** Transplant

## Key facts

- **NCT ID:** NCT00449319
- **Lead sponsor:** Gruppo Italiano Malattie EMatologiche dell'Adulto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1998-11
- **Primary completion:** 2018-06
- **Final completion:** 2018-07
- **Target enrollment:** — (—)
- **Last updated:** 2017-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00449319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00449319, "AML Treatment in Untreated Adult Patients". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00449319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*